Topics

Clinical study shows RenalGuard Therapy prevents post cardiac surgery AKI

06:48 EST 8 Nov 2019 | Compelo Medical Devices

US-based medical device company RenalGuard Solutions reported that its RenalGuard Therapy has demonstrated better results in KIDNEY clinical trial, compared to standard-of-care hydration. The company said that its

The post Clinical study shows RenalGuard Therapy prevents post cardiac surgery AKI appeared first on NS Medical Devices.

Original Article: Clinical study shows RenalGuard Therapy prevents post cardiac surgery AKI

NEXT ARTICLE

More From BioPortfolio on "Clinical study shows RenalGuard Therapy prevents post cardiac surgery AKI"

Quick Search

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Endocrinology
Diabetes Diabetes Endocrine Disorders Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several g...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...